You just read:

Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)

News provided by

Regeneron Pharmaceuticals, Inc.

Dec 20, 2010, 01:10 EST